Clinical Trial Update: Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety, efficacy, and pharmacokinetics of EYN-1601 for dilation of the pupil (mydriasis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mydriasis

Drugs mentioned

• EYN-1601

Snippet

Sponsor: Eyenovia Inc. | Conditions: Mydriasis | Phase 2 | Status: COMPLETED